Chad Neely, Chief Executive Officer
Chad is the founder and CEO of Wenzel Spine. Chad has spent over 13 years in the Life Science industry, both in leading Wenzel Spine and working in mid-market business finance, specializing in Life Science transactions. Under his direction, Wenzel Spine has grown from an idea to redefine minimally invasive spine surgery into a high growth medical device company with unique and proven products. Chad’s commitment and passion for building top-performing teams, creating a collaborative and innovative work environment, and focusing continuously on the needs of surgeons and their patients has enabled Wenzel Spine’s rapid growth and prepared the business for future expansion and scale.
Chad has extensive experience working with companies managing sales/marketing, strategic planning and product development. Previous to Wenzel Spine, Chad was a Vice President with the Merrill Lynch small and middle market business finance group and Vice President with the Comerica Technology & Life Science team.
William Wilson, Chief Operating Officer
Bill is the Chief Operating Officer for Wenzel Spine. Bill has built his career as an operations and organization management leader and is responsible for the development of the operations, finance, client relations, marketing, and medical education teams at Wenzel Spine. Bill’s experience and expertise have enabled him to expertly manage the continually expanding team and product portfolio. He is focused on ensuring that the company’s growth is always focused on our surgeon partners and bringing value to their patients, as well as continually growing the exceptional Wenzel Spine team.
Prior to joining Wenzel Spine, Bill lead a Product Group Strategy team at Dell. As a Six Sigma black belt, Bill lead key strategic efforts to leverage new efficiency methods to improve operations and drastically reduce product warranty costs.
Kim Krugman, Director of Clinical, Regulatory and Quality Affairs
Kim is Wenzel Spine’s Director of Clinical, Regulatory and Quality Affairs. As Director of Clinical, Quality, and Regulatory Affairs Kim's team is focused on evidence development and dissemination, maintaining excellence in the quality of our implants, and enabling market access through regulatory bodies. A veteran of the medical device industry, Kim started her career as an engineer in radiofrequency technologies for interventional oncology and crossed over to clinical sciences. Kim has worked on a wide technology base including complex electrosurgical generators, disposable OR instruments, ultrasonic platforms, biofeedback, and the last several years have been dedicated to spine implants.
Kim and her team bring a wealth of experience in managing quality, regulatory, and clinical initiatives on Class I to Class III devices and is poised to help Wenzel achieve it's trajectory of business expansion into the future.
Andi Cragen, Director of Product Development
Andi is the Director of Product Development for Wenzel Spine. As Product Development Leader, Andi is focused on Wenzel Spine’s product strategy and supporting engineering functions that simplify spine surgery for both surgeons and patients. Together with her team of outstanding development engineers, Wenzel Spine’s product development team has over 40 years of orthopedic and spine product development and engineering experience.
The engineering team’s ability to innovate and rapidly drive quality products to market has enabled Wenzel Spine to offer unique products that redefine minimally invasive surgical techniques to its surgeon partners. The team’s dedication has enabled the company to offer exceptionally high-quality product systems that are both reliable and scalable.
Prior to joining Wenzel Spine, Andi held senior product development and engineering positions with NanoMedical Systems and Zimmer.
Jeffrey Arle, MD, PhD
Jeff Arle, MD, PhD, FAANS is currently the Associate Chief of Neurosurgery at the Beth Israel Deaconess Medical Center in Boston, the Chief of Neurosurgery at Mt. Auburn Hospital in Cambridge and an Associate Professor of Neurosurgery at Harvard Medical School. He is a full-time neurosurgeon and specialist in both complex spine and functional neurosurgery and a member of BIDMC Spine Center, one of the busiest in the Boston region. He is on the editorial board of two prominent journals, Neurosurgery and Neuromodulation, and frequently reviews articles for several other journals. He is currently the Co-chair of the Research and Scientific Policy Committee of the International Neuromodulation Society as well as on the Executive Board for the International Society of Intraoperative Neurophysiology. He has been involved in research on cervical interbody fusions and pedicle screw stimulation, as well as publishing over 60 peer-reviewed articles, 23 textbook chapters, edited 2 textbooks, and given over 75 national and international talks. His research interests and efforts are focused primarily on computational modeling of neural stimulation therapies and mechanisms.
Adam Lewis, MD
Dr. Adam Lewis began his distinguished medical career at Harvard University where he received his B.A. in 1986. He went on from there to receive his M.D. from Georgetown University and continued his internship and residency at the University of Cincinnati Medical Center from 1990-1995. He later trained in multiple spinal treatment techniques and developed instrumentation for spinal procedures. He has received multiple research grants from national institutes and the University of Mississippi Medical Center. An avid researcher, Dr. Lewis has written and co-written over 50 works in the field of neuroscience to showcase his knowledge as a spine and brain specialist. Dr. Adam Lewis is one of the top neurosurgeons out there.
Dr. Lewis is also a prized teacher and speaker having delivered lectures at the University of Cincinnati College of Medicine, the American Association of Neurological Surgeons, and in recent years at the St. Dominic’s Neuroscience Conferences. He has also served as an Assistant Professor in Neurosurgery at UMMC, and he is the owner and president of the Jackson Neurosurgery Clinic, one of the most successful clinics of its kind in the Southeast.
Andrew D. Fine, MD
Dr. Andrew Fine specializes in the treatment of brain and spine problems using minimally invasive techniques. He received his Doctor of Medicine from the University of Florida College of Medicine in Gainesville, where he also completed his Post-Doctoral training and residency. Dr. Fine is board certified by the American Board of Neurological Surgery and licensed in the State of Florida. His hospital appointments include Sarasota Memorial Hospital, Doctors Hospital of Sarasota, Doctors Same Day Surgery and Cape Surgery Centers. Dr. Fine is widely published and regarded for his scholarly presentations; Dr. Fine is a member of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons. In 2009 Dr. Fine received the Patients Choice On Time Physician Award from the American Registry of Business Excellence.
Frank Fichtel, MD
Dr. Frank Fichtel is a highly respected neurological surgeon specializing in adult neurosurgery. He provides invaluable technical and clinical expertise to advance minimally invasive surgical solutions by reducing recovery time and improving clinical outcomes for patients. Dr. Fitchel graduated from Baylor University Medical School and went on to complete his residency and internship at the University of Texas Southwestern Affiliated Hospitals in Dallas. He currently remains active in several professional medical organizations.
Developing Solutions to Simplify Spine Surgery.
We passionately strive to help our surgeons improve the lives of the patient’s in their care.
Delivering on the Commitments We Make.
We empower our employees to take ownership and constantly innovate. Bringing first in class service and technologies to surgeons and partners.
Measuring Results Across the System.
Our team is dedicated to delivering solutions that have a positive impact across the entire healthcare system.
Valuing Every Person at Wenzel Spine.
We believe that the single greatest asset at Wenzel Spine is our people.
Transparency & Ethics
We implemented our Corporate Compliance Program in April of 2010 and hold all employees and partners to the principles and regulations contained in our Compliance Program.
At Wenzel Spine, transparency is integral to delivering on our commitment to uncompromised integrity. Our team is committed to managing all of our relationships with healthcare professionals in an ethical and transparent manner. We understand the potential problems caused by conflicts of interest and the seriousness of healthcare fraud and abuse. Our corporate compliance program was developed and implemented to ensure ethical business practices from our top management, independent sales force, and consulting healthcare professionals.
Commitment To Quality
At Wenzel Spine, our goal is to manufacture products of the highest quality to support our surgeon customers in the care and treatment of their patients. Wenzel Spine works to maintain a reputation for customer-focused quality by consistently fulfilling surgeons’ expectations. The Wenzel Spine Quality Management System enhances customer confidence and safety, improves conformity to quality requirements, and ensures adherence to regulatory requirements.
Recent News & Events
A Message to Wenzel Spine's Clients & Partners
Mar 27, 2020
Dear Clients & Partners,
The spread of the COVID-19 virus has created an unprecedented challenge to the global community, and in particular, the healthcare industry. Many of the professionals that we work with every day are now on the front lines of the battle to contain the outbreak and treat patients.Read more…
Wenzel Spine Announces FDA Clearance to Include Allograft with the VariLift® Product Family
Feb 21, 2019
We are pleased to have recently received clearance from the U.S. Food and Drug Administration (FDA) to market our Expandable Stand-Alone VariLift® systems for use with allograft.
Wenzel Spine’s VariLift® Platforms Now Provide the Broadest Clearance of an Expandable Interbody Fusion Device on the Market.
When expanded, the large fenestrations of our VariLift® devices allow for maximum bone to graft contact as well as overpacking the disc space with graft material post implantation and expansion. This new FDA clearance will give surgeons more options in sourcing the graft tissue that meets their patients specific needs. Check out the video below to see the VariLift®-LX graft chamber in action.Read more…
Wenzel Spine in Los Angeles to Attend NASS 2018
Aug 24, 2018
1130 Rutherford, Suite 200
Austin, TX 78753